Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DUAL: Asunaprevir and Daclatasvir for Chronic Hepatitis C Genotype 1b (Phase 3)
2011-005446-35Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of asunaprevir, daclatasvir in chronic hepatitis C (CHC), sponsored by Bristol Myers Squibb. Started May 2012; status: completed.
02
Drugs
asunaprevirdaclatasvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on 2011-005446-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005446-35.